NEW YORK, Aug. 5, 2016 /PRNewswire/ --
American Renal Associates Holdings, Inc. (ARA)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of ARA.
Specifically, UnitedHealth Group, Inc. recently sued ARA alleging
that ARA engaged in a fraudulent scheme to obtain larger payments
than were really due.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Avinger, Inc. (AVGR)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of
Avinger. Specifically, on July 12,
2016, Avinger announced expected total revenue of
$4.7 million for the second quarter
vs. the consensus estimate of $5.70
million; and expected 2016 revenue of $19 - $23 million, compared to previous guidance
for revenue of $25 - $30 million.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
CytRx Corporation (CYTR)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of CYTR.
Specifically, whether the clinical hold placed on the Phase 3 trial
of aldoxorubicin for STS would prevent sufficient follow-up for
patients involved in the study.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
El Pollo Loco Holdings, Inc. (LOCO)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of LOCO.
Specifically, in May 2015, following
the announcement of strong first quarter 2015 results five Pollo
Loco insiders sold over 6 million shares for total proceeds of
approximately $131 million at prices
prior to the August 2015 announcement
disclosing disappointing second quarter results.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
EndoChoice Holdings, Inc. (GI)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of
EndoChoice. Specifically, on June 5,
2015, EndoChoice launched its IPO and recently revealed a
drop in Fuse placements in the third quarter.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
Full Circle Capital Corporation (FULL)
Lifshitz & Miller announces investigation into possible
breaches of fiduciary duties in connection with the proposed sale
of FULL to Great Elm Capital Corp.
For more information about our investigation, please contact
Joshua M. Lifshitz, Esq. by telephone at (516) 493-9780 or by
sending an e-mail including your contact information to:
info@jlclasslaw.com.
ZIOPHARM Oncology, Inc. (ZIOP)
Lifshitz & Miller announces investigation into
possible breaches of fiduciary duties by the board of ZIOP.
Specifically, on July 14, 2016,
Ziopharm revealed that a brain cancer patient in an ongoing
clinical trial had died after being treated with Ad-RTS-hIL-12.
For more information about our investigation, please complete
the Information Request Form or contact Joshua Lifshitz, Esq. by
telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.
ATTORNEY ADVERTISING. © 2016 Lifshitz &
Miller. The law firm responsible for this advertisement is
Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel:
(516)493-9780. Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz,
Esq.
Lifshitz & Miller
Phone: 516-493-9780
Facsimile: 516-280-7376
Email:
info@jlclasslaw.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-american-renal-associates-holdings-inc-cytrx-corporation-el-pollo-loco-holdings-inc-endochoice-holdings-inc-full-circle-capital-corporation-and-ziopharm-oncology-inc-300309923.html
SOURCE Lifshitz & Miller Law Firm